Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

  • SEC EDGAR•filings
    8-K - GRAN TIERRA ENERGY INC. (0001273441) (Filer)

    Gran Tierra Energy Inc. filed a Form 8-K on October 9, 2026, reporting a submission of matters to a vote of security holders (Item 5.07), other events (Item 8.01), and accompanying financial statements and exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Filer)

    Integra Lifesciences Holdings Corp filed a Form 8-K on October 9, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Aldel Financial II Inc. (0002031561) (Filer)

    Aldel Financial II Inc. filed a Form 8-K reporting entry into a material definitive agreement, amendments to its articles of incorporation and fiscal year, a shareholder vote, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Sunshine Biopharma Inc. (0001402328) (Filer)

    Sunshine Biopharma Inc. filed a Form 8-K on October 9, 2026 reporting entry into a material definitive agreement, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Flyte Aviation, Inc. (0001716621) (Filer)

    Flyte Aviation, Inc. filed a Form 8-K on October 9, 2026 reporting unregistered sales of equity securities, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Streamex Corp. (0001530766) (Filer)

    Streamex Corp. filed a Form 8-K on October 9, 2026, disclosing a notice of delisting or failure to satisfy a continued listing rule and including its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Serina Therapeutics, Inc. (0001708599) (Filer)

    Serina Therapeutics, Inc. filed a Form 8-K on October 9, 2026 reporting amendments to its articles of incorporation or bylaws, a change in its fiscal year, and the inclusion of financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Arrive AI Inc. (0001818274) (Filer)

    Arrive AI Inc. filed a Form 8-K on October 9, 2026 reporting a material definitive agreement, unregistered sales of equity securities, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Volato Group, Inc. (0001853070) (Filer)

    Volato Group, Inc. filed an 8-K reporting a material definitive agreement, unregistered equity sales, changes to security-holder rights, amendments to its articles/bylaws and fiscal year, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Quantum Cyber N.V. (0001874252) (Filer)

    Quantum Cyber N.V. filed a Form 8-K on October 9, 2026, disclosing entry into a material definitive agreement and including its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Vistagen Therapeutics, Inc. (0001411685) (Filer)

    Vistagen Therapeutics, Inc. filed a Form 8-K on October 9, 2026, reporting the departure, election or appointment of certain directors and officers and related compensatory arrangements, and providing its financial statements and accompanying exhibits.

  • SEC EDGAR•filings
    8-K - ARTELO BIOSCIENCES, INC. (0001621221) (Filer)

    Artelo Biosciences, Inc. filed a Form 8-K with the SEC on October 9, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001640334-26-001665, 143 KB).

  • SEC EDGAR•filings
    8-K - MOBIX LABS, INC (0001855467) (Filer)

    Mobix Labs, Inc. filed a Form 8-K on October 9, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - Moleculin Biotech, Inc. (0001659617) (Filer)

    Moleculin Biotech, Inc. filed a Form 8-K on October 9, 2026 reporting director and officer departures, elections, compensatory arrangements, shareholder voting matters, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Starfighters Space, Inc. (0001947016) (Filer)

    Starfighters Space, Inc. filed a Form 8-K on October 9, 2026 reporting amendments to its articles of incorporation or bylaws, a change in its fiscal year, and providing accompanying financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - AgEagle Aerial Systems Inc. (0000008504) (Filer)

    AgEagle Aerial Systems Inc. filed a Form 8-K reporting the departure of certain directors or officers, the election or appointment of new directors/officers, and related compensatory arrangements for those officers.

  • SEC EDGAR•filings
    8-K - Niki BioSolutions, Inc. (0001734005) (Filer)

    Niki BioSolutions filed a Form 8-K on October 9, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K/A - Invesco Ltd. (0000914208) (Filer)

    Invesco Ltd. submitted a Form 8-K/A on October 9, 2026 (Accession No. 0000914208-26-000360), containing a Regulation FD disclosure and accompanying financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - SolarMax Technology, Inc. (0001519472) (Filer)

    SolarMax Technology, Inc. filed a Form 8-K on October 9, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - Vivakor, Inc. (0001450704) (Filer)

    Vivakor, Inc. filed a Form 8-K on October 9, 2026, disclosing unregistered sales of equity securities, a Regulation FD disclosure, and accompanying financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Crescent Energy Co (0001866175) (Filer)

    Crescent Energy Co filed a Form 8-K on October 9, 2026 (Accession No. 0001628280-26-065552), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Live Nation Entertainment, Inc. (0001335258) (Filer)

    Live Nation Entertainment, Inc. filed a Form 8-K on October 9, 2026 (Accession No. 0001335258-26-000046), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.

  • SEC EDGAR•filings
    8-K - Sidus Space Inc. (0001879726) (Filer)

    Sidus Space Inc. filed a Form 8-K on October 9, 2026 reporting departures, elections or appointments of directors and certain officers, related compensatory arrangements, and providing its financial statements and accompanying exhibits.

  • SEC EDGAR•filings
    8-K - Sintx Technologies, Inc. (0001269026) (Filer)

    Sintx Technologies filed an 8-K on October 9, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - NextBoat Inc. (0002067767) (Filer)

    NextBoat Inc. filed a Form 8-K on October 9, 2026 disclosing departures of directors or certain officers, elections of directors, appointments of officers and related compensatory arrangements under Item 5.02.

  • SEC EDGAR•filings
    8-K - HEALTHEQUITY, INC. (0001428336) (Filer)

    Healthequity, Inc. filed a Form 8-K reporting the departure of directors or certain officers, the election and appointment of directors and officers, and related compensatory arrangements.

  • SEC EDGAR•filings
    8-K - DarkPulse, Inc. (0000866439) (Filer)

    DarkPulse, Inc. submitted a Form 8-K filing under Item 8.01 (Other Events) on October 9, 2026, with accession number 0001683168-26-007752 and a document size of 179 KB.

  • SEC EDGAR•filings
    8-K - Copley Acquisition Corp (0002045473) (Filer)

    Copley Acquisition Corp filed an 8-K on October 9, 2026 reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Cosmos Health Inc. (0001474167) (Filer)

    Cosmos Health Inc. filed a Form 8-K on October 9, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Profusa, Inc. (0001859807) (Filer)

    Profusa, Inc. filed a Form 8-K on October 9, 2026, reporting a change in its certifying accountant and including its financial statements and related exhibits.